Market Tracker

05/28 6:01pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

13.48
Delayed Data
As of May 28
 -0.03 / -0.22%
Today’s Change
7.31
Today|||52-Week Range
14.07
+62.41%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close13.51
Today’s open13.45
Day’s range13.35 - 13.62
Volume648,704
Average volume (3 months)794,563
Market cap$645.3M
Dividend yield--
Data as of 4:00pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-57.03%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio19.1
Price/Sales2.87
Price/Book8.14

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.01+0.08%
NWBONorthwest Biotherape...-0.02-0.24%
DVAXDynavax Technologies...+0.15+0.67%
CORTCorcept Therapeutics...+0.08+1.38%
Data as of 4:00pm ET, 05/28/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts